Related Experiment Videos

[Clinical analysis of Streptococcus faecalis septicemia in children]

J Szymborski1, M Komar

  • 1Szpitala Dzieciecego Specjalistycznego Zespołu Opieki Zdrowotnej nad Matka i Dzieckiem w Wałbrzychu.

Przeglad Lekarski
|January 1, 1990
PubMed

Insights

Streptococcus faecalis sepsis in infants presents similarly to other Gram-positive sepsis, with significant drug resistance. This study analyzed 59 infant cases, revealing a 10.2% mortality rate.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Neonatal Care

Background:

  • Streptococcus faecalis (now Enterococcus faecalis) is a notable cause of sepsis in infants.
  • Understanding the clinical characteristics and resistance patterns of this pathogen is crucial for effective treatment.

Purpose of the Study:

  • To analyze the clinical features, drug resistance, and outcomes of Streptococcus faecalis sepsis in infants.
  • To identify risk factors and complications associated with this infection in a vulnerable population.

Main Methods:

  • Retrospective clinical analysis of 59 infant cases (1-5 months old) with Streptococcus faecalis sepsis.
  • Characterization of isolated bacterial strains for antimicrobial resistance, particularly to penicillin and its derivatives.
  • Review of clinical presentations, complications (e.g., meningitis, intrauterine infection), and mortality.

Main Results:

  • Isolated Streptococcus faecalis strains exhibited significant drug resistance, especially to penicillin.
  • Clinical presentation was largely similar to other Gram-positive sepsis.
  • Meningitis occurred in 20% of cases; intrauterine infection was observed in about one-third of neonates.
  • The overall mortality rate for Streptococcus faecalis sepsis in this cohort was 10.2%.

Conclusions:

  • Streptococcus faecalis sepsis in infants poses a significant threat, characterized by drug resistance and potential for severe complications like meningitis.
  • Early diagnosis and appropriate antibiotic selection are critical, considering the observed resistance patterns.
  • The findings underscore the importance of monitoring antimicrobial resistance in neonatal and pediatric intensive care units.

Related Concept Videos